Golestan University of Medical Sciences Repository

Items where Author is "Abbaszadeh-Goudarzi, K."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 8.

Article

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2018) Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2018) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology.

This list was generated on Sun Apr 21 05:26:50 2019 IRDT.